Quironsalud
8
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
Role: lead
Prevalence of DAO (diamino Oxidase) Deficiency in Newborns
Role: collaborator
Analysis of Bone Quality in Adult Patients With Inflammatory Bowel Disease
Role: lead
Psycho-oncological Intervention Through Counselling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine
Role: lead
Effects of Myofunctional Therapy With an Application in Severe Apnea/Hypopnea Sleep Obstructive Syndrome (MTASSAOS)
Role: lead
Immediate and Mid-term Effect of a Natural Topical Product in Patients With Musculoskeletal Pain
Role: collaborator
Imaging Biomarkers of the Effects of a Mixed Exercise Program
Role: collaborator
Endoscopic Full-Thickness Resection In Colon
Role: collaborator
All 8 trials loaded